ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CDSW Cedara Software Corp (MM)

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Cedara Software Corp (MM) NASDAQ:CDSW NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Cedara OrthoWorks Care Manager(TM) Named Product Innovation of the Year by Frost & Sullivan

26/05/2005 4:29pm

PR Newswire (US)


Cedara (NASDAQ:CDSW)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Cedara Charts.
Cedara OrthoWorks Care Manager(TM) Named Product Innovation of the Year by Frost & Sullivan TORONTO, May 26 /PRNewswire-FirstCall/ -- CEDARA SOFTWARE CORP. (TSX:CDE/NASDAQ:CDSW), a leading independent provider of medical imaging technologies for the global healthcare market, has been awarded Product Innovation of the Year by Frost & Sullivan LLC for its Cedara OrthoWorks Care Manager. Cedara OrthoWorks Care Manager is a powerful clinical data management system that organizes clinical information, allowing data analysis and manipulation. Useful for multi-centric studies, orthopaedic implant tracking, insurance claim evaluations and systematic patient clinical follow-up, Care Manager has widespread applications throughout the healthcare industry. In reference to the award, Frost & Sullivan Analyst Sachin Thukral said "Orthopedic surgeons usually maintain manual records of surgeries with separate records for care and recovery. This 'hard copy approach' makes it time consuming for surgeons and technicians to perform statistical analysis and visualize trends. In order to simplify and accelerate the process, Cedara Software has provided the healthcare community with Orthoworks Care Manager. This revolutionary tool facilitates efficient data mining and statistical analysis and ultimately helps provide real-time feedback for patient treatment strategies." OrthoWorks Care Manager was developed in association with one of Cedara's technology partners, SurgiView, a Paris-based company known for developing transversal tools based on software technologies dedicated to clinical data management for different surgical & medical specialties. OrthoWorks Care Manager employs a proprietary technology that captures relevant clinical parameters during diagnosis, therapy and post-therapy follow-up, which transfers the data into a structured query language (SQL) database. It is equipped with powerful, yet intuitive data-mining tools to perform outcome analysis that in turn can be analyzed by statistical packages. OrthoWorks Care Manager promotes data sharing between various centers via a secure e-mail system, thereby allowing the exchange of information, and/or centralization of data in case of multi-center studies. Furthermore, OrthoWorks Care Manager, which represents a confluence of imaging capabilities and data mining techniques, saves surgeons valuable time and vastly accelerates data compilation. OrthoWorks Care Manager features an exclusive repository where a surgeon can access key orthopedic and image data. As part of the OrthoWorks suite of applications, image-generated data such as hard tissue measurements and volumes can be automatically populated into Care Manager, eliminating potential data entry errors and expediting workflow. When used in conjunction with Cedara OrthoWorks Spine Analyzer(TM), spinal measurements can be quickly tracked in this fashion to better understand the benefits of a surgery, or to analyze tendency of outcomes in a population during a study. Other applications could include automated tracking of tumour dimensions and cartilage thickness through Care Manager. The Cedara OrthoWorks product line includes applications that allow: - Multi modality viewing capabilities from one workstation - Customized scripts that mimic orthopaedic planning methodologies - Standalone or remote Web-Based orthopaedic surgical planning - Real-time 3D Reconstruction to identify structures and/or remove obscuring tissue Cedara OrthoWorks Care Manager was evaluated by Frost & Sullivan on a variety of different criteria for the Product Innovation of the Year Award, including product significance, competitive advantage, innovation and acceptance in a given marketplace. Product launches and new products in development from different companies were compared and evaluated based on their degree of innovation and customer satisfaction. In selecting a recipient, the analyst team tracked new product launches, R&D spending, products in development, as well as new product features and modifications. Marwan Sati, Director of Medical Applications at Cedara Software said, "It is an honour to receive Frost & Sullivan's Product Innovation of the Year award. Care Manager is a powerful application that was developed by surgeons for surgeons, which has allowed us to solve many of the problems present in clinical data management today. For implant manufacturers, Care Manager can assist in the tracking and analyzing of implant usage, pain thresholds, recovery rates, complications, mobility, mortality and a host of other clinical outcome statistics. Care Manager will play a key role in improving patient care." About Cedara Software Corp. Cedara Software Corp. is a leading independent provider of medical imaging technologies. Cedara's software is deployed in hospitals and clinics worldwide and is licensed by many of the world's leading medical device and healthcare information technology companies. Approximately 28,000 medical imaging systems and 6,400 Picture Archiving and Communications System (PACS) workstations have been licensed to date. Cedara recently acquired eMed Technologies Corporation, widely known as a provider of innovative PACS and teleradiology solutions that have been installed in over 2,000 hospitals and imaging centres. Cedara is unique in that it has technologies and expertise that span all the major digital imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray, mammography, ultrasound, echo-cardiology, angiography, nuclear medicine, positron emission tomography (PET) and fluoroscopy. Furthermore, the Company's medical imaging offerings are used in all aspects of clinical workflow including the capture of a patient's digital image; the archiving, communication and manipulation of digital images; sophisticated clinical applications to analyze digital images; and even the use of imaging in minimally-invasive surgery. On January 18, 2005, Cedara announced that it had signed a definitive agreement to merge with Merge Technologies Incorporated (NASDAQ:MRGE), d.b.a. Merge eFilm, in an all-stock transaction. The merger is subject to court approval and is expected to close on or about June 1, 2005. Certain statements contained in this news release are forward-looking within the meaning of securities laws and are based on current expectations that are subject to a number of assumptions, uncertainties and risks, and the actual results may differ materially from what is currently expected. In particular, statements relating to the healthcare imaging software market and market share, relating to the Company's expectations concerning its licensed software products, relating to the Company's expectations as to revenues, costs and cash flows, relating to the acquisition of eMed and relating to the proposed merger with Merge eFilm are forward-looking statements. The assumptions, uncertainties and risks upon which these forward looking statements are based include, but are not limited to: dependence on key personnel of the Company, dependence on major customers and individual contracts, fluctuations in quarterly financial results, competitive pressures (including price competition), rapid technological change, exchange rate fluctuations, risks associated with international operations, dependence on intellectual property rights, regulatory clearances and approvals for new products, risks relating to product defects and product liability, adverse consequences of financial leverage, ability to service debt, continued acceptance of the Company's products, regulatory changes to the health care industry, seasonality, economic and political conditions, risks relating to the acquisition of eMed and risks relating to the proposed merger with Merge eFilm including risks associated with obtaining regulatory and shareholder approvals without unexpected delays or conditions, timely implementation and execution of merger integration plans, retention of customers and the Company's original employees, successfully leveraging Merge eFilm's and the Company's comprehensive product offering to the combined customer base and sustaining continued growth at rates approximating recent levels. Further information about these risks and uncertainties can be found in the continuous disclosure documents filed from time to time by Cedara with the securities regulatory authorities, which documents are available at http://www.sedar.com/. For more information, visit the Cedara website at http://www.cedara.com/. All trademarks appearing in this release are the property of Cedara Software Corp. DATASOURCE: Cedara Software Corp. CONTACT: Jacques Cornet, VP of Marketing & Operations, Cedara Software Corp., (905) 672-2100 ext. 2564, ; To request a free copy of this organization's annual report, please go to http://www.newswire.ca/ and click on reports@cnw.

Copyright

1 Year Cedara Chart

1 Year Cedara Chart

1 Month Cedara Chart

1 Month Cedara Chart

Your Recent History

Delayed Upgrade Clock